Clinical Trial: Nasal Spray Dry Eye Treatment

U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606625) titled 'Nasal Spray Dry Eye Treatment' on May 19.

Brief Summary: The purpose of this study is to examine the impact of nasal spray treatment on Meibomian gland function and ocular surface health in symptomatic dry eye patients with mild to moderate Meibomian gland dysfunction (MGD).

Study Start Date: March 06

Study Type: INTERVENTIONAL

Condition: Dry Eye Meibomian Gland Dysfunction

Intervention: DRUG: Varenicline 0.03Mg/Spray Nasal Soln

After meeting eligibility criteria and signing informed consent, participants will be dispensed a 3-month supply of varenicline 0.03mg/spray nasal solution. Participants will take the nasal spray home ...